CIGNA Co. (NYSE:CI) – Stock analysts at Jefferies Group increased their Q1 2018 earnings estimates for CIGNA in a research report issued on Friday. Jefferies Group analyst D. Windley now forecasts that the health services provider will post earnings per share of $3.50 for the quarter, up from their previous forecast of $3.22. Jefferies Group has a “Buy” rating and a $231.00 price objective on the stock. Jefferies Group also issued estimates for CIGNA’s Q2 2018 earnings at $3.51 EPS, Q3 2018 earnings at $3.48 EPS and Q4 2018 earnings at $2.65 EPS.
CIGNA (NYSE:CI) last announced its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, topping the Zacks’ consensus estimate of $2.36 by $0.47. CIGNA had a return on equity of 18.85% and a net margin of 5.74%. The firm had revenue of $10.38 billion during the quarter, compared to analyst estimates of $10.17 billion. During the same period last year, the company posted $1.94 EPS. The business’s quarterly revenue was up 5.1% compared to the same quarter last year.
CIGNA (NYSE CI) traded up $2.50 on Monday, hitting $213.39. The stock had a trading volume of 1,151,200 shares, compared to its average volume of 1,110,533. CIGNA has a 52 week low of $133.52 and a 52 week high of $213.73. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.39 and a quick ratio of 0.39. The stock has a market cap of $53,160.00, a P/E ratio of 23.37, a PEG ratio of 1.43 and a beta of 0.51.
In other CIGNA news, CAO Mary T. Hoeltzel sold 575 shares of the firm’s stock in a transaction that occurred on Thursday, November 9th. The stock was sold at an average price of $197.03, for a total value of $113,292.25. Following the sale, the chief accounting officer now owns 2,499 shares of the company’s stock, valued at approximately $492,377.97. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP John M. Murabito sold 28,037 shares of the firm’s stock in a transaction that occurred on Wednesday, January 10th. The shares were sold at an average price of $205.68, for a total value of $5,766,650.16. Following the completion of the sale, the executive vice president now directly owns 60,290 shares in the company, valued at approximately $12,400,447.20. The disclosure for this sale can be found here. Insiders sold a total of 63,185 shares of company stock worth $12,789,459 over the last three months. 1.30% of the stock is owned by company insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Capstone Investment Advisors Netherlands B.V. acquired a new stake in shares of CIGNA during the 2nd quarter worth approximately $106,000. Saratoga Research & Investment Management acquired a new stake in shares of CIGNA during the 3rd quarter worth approximately $112,000. Horan Capital Advisors LLC. acquired a new stake in shares of CIGNA during the 3rd quarter worth approximately $123,000. Acrospire Investment Management LLC grew its holdings in shares of CIGNA by 66.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,000 shares of the health services provider’s stock worth $167,000 after purchasing an additional 400 shares in the last quarter. Finally, Grove Bank & Trust grew its holdings in shares of CIGNA by 171.9% during the 3rd quarter. Grove Bank & Trust now owns 976 shares of the health services provider’s stock worth $182,000 after purchasing an additional 617 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
WARNING: This article was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://www.com-unik.info/2018/01/16/q1-2018-earnings-forecast-for-cigna-co-issued-by-jefferies-group-ci.html.
CIGNA Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
What are top analysts saying about CIGNA? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CIGNA and related companies.